Ubiquitin-like proteins

Annual Review of Biochemistry

Volumn 81, Issue , 2012, Pages 323-357

  Van Der Veen, Annemarthe G ^a   Ploegh, Hidde L ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

autophagy; Hub1; ISG15; Nedd8; SUMO; Urm1

Indexed keywords

UBIQUITIN; UBIQUITIN LIKE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; ENZYME SUBSTRATE; HOMEOSTASIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FAMILY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN TRANSPORT; RNA TRANSLATION; VIRUS INHIBITION;

AMINO ACID MOTIFS; ANIMALS; CELL PHYSIOLOGICAL PROCESSES; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUMOYLATION; UBIQUITINS; YEASTS;

EUKARYOTA;

EID: 84861902139     PISSN: 00664154     EISSN: 15454509     Source Type: Book Series    
DOI: 10.1146/annurev-biochem-093010-153308     Document Type: Article

References (258)

1. Hochstrasser M. 2009. Origin and function of ubiquitin-like proteins. Nature 458:422-29
2. Komander D. 2009. The emerging complexity of protein ubiquitination. Biochem. Soc. Trans. 37:937-53
3. Schulman BA, Harper JW. 2009. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat. Rev. Mol. Cell Biol. 10:319-31
4. Mishra SK, Ammon T, Popowicz GM, Krajewski M, Nagel RJ, et al. 2011. Role of the ubiquitin-like protein Hub1 in splice-site usage and alternative splicing. Nature 474:173-78
5. Tatsumi K, Yamamoto-Mukai H, Shimizu R, Waguri S, Sou YS, et al. 2011. The Ufm1-activating enzyme Uba5 is indispensable for erythroid differentiation in mice. Nat. Commun. 2:181
6. Jeon YJ, Yoo HM, Chung CH. 2010. ISG15 and immune diseases. Biochim. Biophys. Acta 1802:485-96
7. Gareau JR, Lima CD. 2010. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11:861-71
8. Wilkinson KA, Henley JM. 2010. Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J. 428:133-45
9. Chen Y, Klionsky DJ. 2011. The regulation of autophagy: unanswered questions. J. Cell Sci. 124:161-70
10. MatunisMJ, Coutavas E, BlobelG. 1996. A novel ubiquitin- likemodificationmodulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135:1457-70
11. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F. 1997. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88:97-107
12. Tatham MH, Jaffray E, Vaughan OA, Desterro JM, Botting CH, et al. 2001. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9. J. Biol. Chem. 276:35368-74
13. Zhang FP, Mikkonen L, Toppari J, Palvimo JJ, Thesleff I, Janne OA. 2008. Sumo-1 function is dispensable in normal mouse development. Mol. Cell. Biol. 28:5381-90
14. Evdokimov E, Sharma P, Lockett SJ, Lualdi M, Kuehn MR. 2008. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3. J. Cell Sci. 121:4106-13
15. Yuan H, Zhou J, Deng M, Liu X, Le Bras M, et al. 2010. Small ubiquitin-related modifier paralogs are indispensable but functionally redundant during early development of zebrafish. Cell Res. 20:185-96
16. Ayaydin F, Dasso M. 2004. Distinct in vivo dynamics of vertebrate SUMO paralogues. Mol. Biol. Cell 15:5208-18
17. Vertegaal AC, Andersen JS, Ogg SC, Hay RT, Mann M, Lamond AI. 2006. Distinct and overlapping sets of SUMO-1 and SUMO-2 target proteins revealed by quantitative proteomics. Mol. Cell Proteomics 5:2298-310
18. Rosas-Acosta G, Russell WK, Deyrieux A, Russell DH, Wilson VG. 2005. A universal strategy for proteomic studies of SUMO and other ubiquitin-like modifiers. Mol. Cell Proteomics 4:56-72
19. Manza LL, Codreanu SG, Stamer SL, Smith DL, Wells KS, et al. 2004. Global shifts in protein sumoylation in response to electrophile and oxidative stress. Chem. Res. Toxicol. 17:1706-15
20. Zhang XD, Goeres J, Zhang H, Yen TJ, Porter AC, Matunis MJ. 2008. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis. Mol. Cell 29:729-41
21. Mabb AM, Wuerzberger-Davis SM, Miyamoto S. 2006. PIASy mediates NEMO sumoylation and NFkappaB activation in response to genotoxic stress. Nat. Cell Biol. 8:986-93
22. Ghisletti S, Huang W, Ogawa S, Pascual G, Lin ME, et al. 2007. Parallel SUMOylation-dependent pathways mediate gene-and signal-specific transrepression by LXRs and PPARgamma. Mol. Cell 25:57-70
23. Shimshon L, Michaeli A, Hadar R, Nutt SL, David Y, et al. 2011. SUMOylation of Blimp-1 promotes its proteasomal degradation. FEBS Lett. 585:2405-9
24. Saitoh H, Hinchey J. 2000. Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3. J. Biol. Chem. 275:6252-58
25. Yang M, Hsu CT, Ting CY, Liu LF, Hwang J. 2006. Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro. J. Biol. Chem. 281:8264-74
26. Pichler A, Gast A, Seeler JS, Dejean A, Melchior F. 2002. The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108:109-20
27. Matic I, Van HagenM, Schimmel J, Macek B, Ogg SC, et al. 2008. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy. Mol. Cell Proteomics 7:132-44
28. Pedrioli PG, Raught B, Zhang XD, Rogers R, Aitchison J, et al. 2006. Automated identification of SUMOylation sites using mass spectrometry and SUMmOn pattern recognition software. Nat. Methods 3:533-39
29. Bylebyl GR, Belichenko I, Johnson ES. 2003. The SUMO isopeptidase Ulp2 prevents accumulation of SUMO chains in yeast. J. Biol. Chem. 278:44113-20
30. Song J, Durrin LK, Wilkinson TA, Krontiris TG, Chen Y. 2004. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. USA 101:14373-78
31. Hecker CM, Rabiller M, Haglund K, Bayer P, Dikic I. 2006. Specification of SUMO1-and SUMO2-interacting motifs. J. Biol. Chem. 281:16117-27
32. Song J, Zhang Z, HuW, Chen Y. 2005. Small ubiquitin-like modifier (SUMO) recognition of a SUMO binding motif: a reversal of the bound orientation. J. Biol. Chem. 280:40122-29
33. Kerscher O. 2007. SUMO junction-what's your function? New insights through SUMO-interacting motifs. EMBO Rep. 8:550-55
34. Meulmeester E, Kunze M, Hsiao HH, Urlaub H, Melchior F. 2008. Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Mol. Cell 30:610-19
35. Zhu J, Zhu S, Guzzo CM, Ellis NA, Sung KS, et al. 2008. Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification. J. Biol. Chem. 283:29405-15
36. Chang CC, Naik MT, Huang YS, Jeng JC, Liao PH, et al. 2011. Structural and functional roles of Daxx SIM phosphorylation in SUMOparalog-selective binding and apoptosis modulation. Mol. Cell 42:62-74
37. Stehmeier P, Muller S. 2009. Phospho-regulatedSUMOinteractionmodules connect the SUMOsystem to CK2 signaling. Mol. Cell 33:400-9
38. Ouyang J, Shi Y, Valin A, Xuan Y, Gill G. 2009. Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex. Mol. Cell 34:145-54
39. Denuc A, Marfany G. 2010. SUMO and ubiquitin paths converge. Biochem. Soc. Trans. 38:34-9
40. Tatham MH, GeoffroyMC, Shen L, Plechanovova A, HattersleyN, et al. 2008. RNF4 is a poly-SUMOspecific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nat. Cell Biol. 10:538-46
41. Martin N, Schwamborn K, Schreiber V, Werner A, Guillier C, et al. 2009. PARP-1 transcriptional activity is regulated by sumoylation upon heat shock. EMBO J. 28:3534-48
42. Mullen JR, Brill SJ. 2008. Activation of the Slx5-Slx8 ubiquitin ligase by poly-small ubiquitin-like modifier conjugates. J. Biol. Chem. 283:19912-21
43. Fryrear KA, Guo X, Kerscher O, Semmes OJ. 2011. The SUMO-targeted ubiquitin ligase RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax. Blood 119:1173-81
44. Mullen JR, Chen CF, Brill SJ. 2010. Wss1 is a SUMO-dependent isopeptidase that interacts genetically with the Slx5-Slx8 SUMO-targeted ubiquitin ligase. Mol. Cell. Biol. 30:3737-48
45. Gilbreth RN, Truong K, Madu I, Koide A, Wojcik JB, et al. 2011. Isoform-specificmonobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design. Proc. Natl. Acad. Sci. USA 108:7751-56
46. Reverter D, Lima CD. 2005. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex. Nature 435:687-92
47. Zhu S, Goeres J, Sixt KM, Bekes M, Zhang XD, et al. 2009. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1. Mol. Cell 33:570-80
48. Pichler A, Knipscheer P, Saitoh H, Sixma TK, Melchior F. 2004. The RanBP2 SUMO E3 ligase is neither HECT-nor RING-type. Nat. Struct. Mol. Biol. 11:984-91
49. Tatham MH, Kim S, Jaffray E, Song J, Chen Y, Hay RT. 2005. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection. Nat. Struct. Mol. Biol. 12:67-74
50. Castano-Miquel L, Segui J, Lois LM. 2011. Distinctive properties of ArabidopsisSUMOparalogs support the in vivo predominant role of AtSUMO1/2 isoforms. Biochem. J. 436:581-90
51. Golebiowski F, Matic I, Tatham MH, Cole C, Yin Y, et al. 2009. System-wide changes to SUMO modifications in response to heat shock. Sci. Signal. 2:ra24
52. Carbia-Nagashima A, Gerez J, Perez-Castro C, Paez-Pereda M, Silberstein S, et al. 2007. RSUME, a small RWD-containing protein, enhancesSUMOconjugation and stabilizesHIF-1alpha during hypoxia. Cell 131:309-23
53. Kang X, Li J, Zou Y, Yi J, Zhang H, et al. 2010. PIASy stimulates HIF1alpha SUMOylation and negatively regulates HIF1alpha activity in response to hypoxia. Oncogene 29:5568-78
54. Zhou W, Ryan JJ, Zhou H. 2004. Global analyses of sumoylated proteins in Saccharomyces cerevisiae. Induction of protein sumoylation by cellular stresses. J. Biol. Chem. 279:32262-68
55. Bossis G, Melchior F. 2006. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol. Cell 21:349-57
56. Han Y, Huang C, Sun X, Xiang B, Wang M, et al. 2010. SENP3-mediated de-conjugation of SUMO2/3 from promyelocytic leukemia is correlated with accelerated cell proliferation under mild oxidative stress. J. Biol. Chem. 285:12906-15
57. Huang C, Han Y, Wang Y, Sun X, Yan S, et al. 2009. SENP3 is responsible for HIF-1 transactivation under mild oxidative stress via p300 de-SUMOylation. EMBO J. 28:2748-62
58. WeiW, Yang P, Pang J, Zhang S, Wang Y, et al. 2008. A stress-dependent SUMO4 sumoylation of its substrate proteins. Biochem. Biophys. Res. Commun. 375:454-59
59. Wang CY, Yang P, Li M, Gong F. 2009. Characterization of a negative feedback network between SUMO4 expression and NFkappaB transcriptional activity. Biochem. Biophys. Res. Commun. 381:477-81
60. Ribet D, Cossart P. 2010. Pathogen-mediated posttranslational modifications: a re-emerging field. Cell 143:694-702
61. Isaacson MK, Ploegh HL. 2009. Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe 5:559-70
62. Chang PC, Izumiya Y, Wu CY, Fitzgerald LD, Campbell M, et al. 2010. Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific. J. Biol. Chem. 285:5266-73
63. BoutellC, Cuchet-Lourenco D, Vanni E, Orr A, GlassM, et al. 2011.A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog. 7:e1002245
64. Marcos-Villar L, Campagna M, Lopitz-Otsoa F, Gallego P, Gonzalez-Santamaria J, et al. 2011. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcoma-associated herpesvirus latent protein LANA2. J. Gen. Virol. 92:188-94
65. Kim ET, Kim YE, Huh YH, Ahn JH. 2010. Role of noncovalent SUMO binding by the human cytomegalovirus IE2 transactivator in lytic growth. J. Virol. 84:8111-23
66. Gonzalez-Santamaria J, Campagna M, Garcia MA, Marcos-Villar L, GonzalezD, et al. 2011. Regulation of vaccinia virus e3 protein by small ubiquitin-like modifier proteins. J. Virol. 85:12890-900
67. Wang L, Oliver SL, Sommer M, Rajamani J, Reichelt M, Arvin AM. 2011. Disruption of PML nuclear bodies is mediated by ORF61 SUMO-interacting motifs and required for varicella-zoster virus pathogenesis in skin. PLoS Pathog. 7:e1002157
68. Rabut G, PeterM. 2008. Function and regulation of protein neddylation. "Protein modifications: beyond the usual suspects" review series. EMBO Rep. 9:969-76
69. Watson IR, IrwinMS, OhhM. 2011.NEDD8pathways in cancer, sine quibus non. Cancer Cell 19:168-76
70. a. Souphron J, Waddell MB, Paydar A, Tokgoz-Gromley Z, Roussel MF, Schulman BA. 2008. Structural dissection of a gating mechanism preventing misactivation of ubiquitin by NEDD8's E1. Biochemistry 47:8961-69
71. Huang DT, Zhuang M, Ayrault O, Schulman BA. 2008. Identification of conjugation specificity determinants unmasks vestigial preference for ubiquitin within the NEDD8 E2. Nat. Struct. Mol. Biol. 15:280-87
72. Hjerpe R, Thomas Y, Chen J, Zemla A, Curran S, et al. 2011. Changes in the ratio of free NEDD8 to ubiquitin triggers NEDDylation by ubiquitin enzymes. Biochem. J. 441(Part 3):927-36
73. Jeram SM, Srikumar T, Zhang XD, Anne EisenhauerH, Rogers R, et al. 2010. An improved SUMmOnbased methodology for the identification of ubiquitin and ubiquitin-like protein conjugation sites identifies novel ubiquitin-like protein chain linkages. Proteomics 10:254-65
74. Jones J, Wu K, Yang Y, Guerrero C, Nillegoda N, et al. 2008. A targeted proteomic analysis of the ubiquitin-like modifier Nedd8 and associated proteins. J. Proteome Res. 7:1274-87
75. Deshaies RJ, Emberley ED, Saha A. 2010. Control of cullin-ring ubiquitin ligase activity by Nedd8. Subcell. Biochem. 54:41-56
76. Broemer M, Tenev T, Rigbolt KT, Hempel S, Blagoev B, et al. 2010. Systematic in vivo RNAi analysis identifies IAPs as NEDD8-E3 ligases. Mol. Cell 40:810-22
77. Chan Y, Yoon J, Wu JT, Kim HJ, Pan KT, et al. 2008. DEN1 deneddylates non-cullin proteins in vivo. J. Cell Sci. 121:3218-23
78. EdelmannMJ, Iphofer A, AkutsuM, Altun M, di Gleria K, et al. 2009. Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem. J. 418:379-90
79. Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA. 2008. Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 134:995-1006
80. Saha A, Deshaies RJ. 2008. Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation. Mol. Cell 32:21-31
81. Yamoah K, Oashi T, Sarikas A, Gazdoiu S, Osman R, Pan ZQ. 2008. Autoinhibitory regulation of SCFmediated ubiquitination by human cullin 1's C-terminal tail. Proc. Natl. Acad. Sci. USA 105:12230-35
82. Merlet J, Burger J, Gomes JE, Pintard L. 2009. Regulation of cullin-RING E3 ubiquitin-ligases by neddylation and dimerization. Cell Mol. Life Sci. 66:1924-38
83. Wu JT, Lin HC, Hu YC, Chien CT. 2005. Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation. Nat. Cell Biol. 7:1014-20
84. He Q, Cheng P, Liu Y. 2005. The COP9 signalosome regulates the Neurospora circadian clock by controlling the stability of the SCFFWD-1 complex. Genes Dev. 19:1518-31
85. Schmidt MW, McQuary PR, Wee S, Hofmann K, Wolf DA. 2009. F-box-directed CRL complex assembly and regulation by the CSN and CAND1. Mol. Cell 35:586-97
86. Wee S, Geyer RK, Toda T, Wolf DA. 2005. CSN facilitates cullin-RING ubiquitin ligase function by counteracting autocatalytic adapter instability. Nat. Cell Biol. 7:387-91
87. Zhou C, Wee S, Rhee E, Naumann M, Dubiel W, Wolf DA. 2003. Fission yeast COP9/signalosome suppresses cullin activity through recruitment of the deubiquitylating enzymeUbp12p. Mol. Cell 11:927-38
88. Liu J, Furukawa M, Matsumoto T, Xiong Y. 2002. NEDD8 modification of CUL1 dissociates p120(CAND1), an inhibitor of CUL1-SKP1 binding and SCF ligases. Mol. Cell 10:1511-18
89. Zheng J, Yang X, Harrell JM, Ryzhikov S, Shim EH, et al. 2002. CAND1 binds to unneddylated CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex. Mol. Cell 10:1519-26
90. Huang DT, Ayrault O, Hunt HW, Taherbhoy AM, Duda DM, et al. 2009. E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol. Cell 33:483-95
91. Kamura T, Conrad MN, Yan Q, Conaway RC, Conaway JW. 1999. The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev. 13:2928-33
92. Calabrese MF, Scott DC, Duda DM, Grace CR, Kurinov I, et al. 2011. A RING E3-substrate complex poised for ubiquitin-like protein transfer: structural insights into cullin-RING ligases. Nat. Struct. Mol. Biol. 18:947-49
93. Kurz T, Chou YC, Willems AR, Meyer-SchallerN, Hecht ML, et al. 2008. Dcn1 functions as a scaffoldtype E3 ligase for cullin neddylation. Mol. Cell 29:23-35
94. Kurz T, Ozlu N, Rudolf F, O'Rourke SM, Luke B, et al. 2005. The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C. elegans and S. cerevisiae. Nature 435:1257-61
95. Scott DC, Monda JK, Grace CR, Duda DM, Kriwacki RW, et al. 2010. A dual E3 mechanism for Rub1 ligation to Cdc53. Mol. Cell 39:784-96
96. Scott DC, Monda JK, Bennett EJ, Harper JW, Schulman BA. 2011. N-terminal acetylation acts as an avidity enhancer within an interconnected multiprotein complex. Science 334:674-78
97. Meyer-Schaller N, Chou YC, Sumara I, Martin DD, Kurz T, et al. 2009. The human Dcn1-like protein DCNL3 promotes Cul3 neddylation at membranes. Proc. Natl. Acad. Sci. USA 106:12365-70
98. HuangG, Kaufman AJ, Ramanathan Y, Singh B. 2011. SCCRO (DCUN1D1) promotes nuclear translocation and assembly of the neddylation E3 complex. J. Biol. Chem. 286:10297-304
99. Rabut G, Le DezG, Verma R, Makhnevych T, Knebel A, et al. 2011. The TFIIH subunit Tfb3 regulates cullin neddylation. Mol. Cell 43:488-95
100. Kamitani T, Kito K, Fukuda-Kamitani T, Yeh ET. 2001. Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1. J. Biol. Chem. 276:46655-60
101. Liu G, Xirodimas DP. 2010. NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways. Oncogene 29:2252-61
102. Dohmesen C, KoeppelM, Dobbelstein M. 2008. Specific inhibition of Mdm2-mediated neddylation by Tip60. Cell Cycle 7:222-31
103. Flomerfelt FA, El Kassar N, Gurunathan C, Chua KS, League SC, et al. 2010. Tbata modulates thymic stromal cell proliferation and thymus function. J. Exp. Med. 207:2521-32
104. Gastaldello S, Hildebrand S, Faridani O, Callegari S, Palmkvist M, et al. 2010. A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases. Nat. Cell Biol. 12:351-61
105. Schlieker C, Korbel GA, Kattenhorn LM, Ploegh HL. 2005. A deubiquitinating activity is conserved in the large tegument protein of the Herpesviridae. J. Virol. 79:15582-5
106. Misaghi S, Balsara ZR, Catic A, Spooner E, Ploegh HL, Starnbach MN. 2006. Chlamydia trachomatisderived deubiquitinating enzymes in mammalian cells during infection. Mol. Microbiol. 61:142-50
107. Artavanis-Tsakonas K, Weihofen WA, Antos JM, Coleman BI, Comeaux CA, et al. 2010. Characterization and structural studies of the Plasmodium falciparum ubiquitin and Nedd8 hydrolase UCHL3. J. Biol. Chem. 285:6857-66
108. Frickel EM, Quesada V, Muething L, Gubbels MJ, Spooner E, et al. 2007. Apicomplexan UCHL3 retains dual specificity for ubiquitin and Nedd8 throughout evolution. Cell Microbiol. 9:1601-10
109. Cui J, Yao Q, Li S, Ding X, Lu Q, et al. 2010. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 329:1215-18
110. Jubelin G, Taieb F, DudaDM, Hsu Y, Samba-Louaka A, et al. 2010. Pathogenic bacteria targetNEDD8-conjugated cullins to hijack host-cell signaling pathways. PLoS Pathog. 6:e1001128
111. Kumar A, Wu H, Collier-Hyams LS, Hansen JM, Li T, et al. 2007. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 26:4457-66
112. Soucy TA, Dick LR, Smith PG, Milhollen MA, Brownell JE. 2010. The NEDD8 conjugation pathway and its relevance in cancer biology and therapy. Genes Cancer 1:708-16
113. Soucy TA, Smith PG, Milhollen MA, Berger AJ, Gavin JM, et al. 2009. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458:732-36
114. Brownell JE, Sintchak MD, Gavin JM, Liao H, Bruzzese FJ, et al. 2010. Substrate-assisted inhibition of ubiquitin-like protein-activating enzymes: the NEDD8 E1 inhibitorMLN4924 forms a NEDD8-AMP mimetic in situ. Mol. Cell 37:102-11
115. Okumura F, Zou W, Zhang DE. 2007. ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev. 21:255-60
116. Zou W, Zhang DE. 2006. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 281:3989-94
117. Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, Zhang DE. 2002. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277:9976-81
118. Catic A, Fiebiger E, Korbel GA, Blom D, Galardy PJ, PloeghHL. 2007. Screen for ISG15-crossreactive deubiquitinases. PLoS One 2:e679
119. Ye Y, Akutsu M, Reyes-Turcu F, Enchev RI, Wilkinson KD, Komander D. 2011. Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21. EMBO Rep. 12:350-57
120. Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O'Guin AK, et al. 2005. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J. Virol. 79:13974-83
121. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, et al. 2007. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. USA 104:1371-76
122. Giannakopoulos NV, Arutyunova E, Lai C, Lenschow DJ, Haas AL, Virgin HW. 2009. ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus. J. Virol. 83:1602-10
123. Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, et al. 2009. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J. Virol. 83:1147-51
124. Ritchie KJ, Hahn CS, Kim KI, Yan M, Rosario D, et al. 2004. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat. Med. 10:1374-78
125. Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, et al. 2006. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol. Cell. Biol. 26:472-79
126. Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP. 2005. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol. Cell. Biol. 25:6338-45
127. Broering R, Zhang X, Kottilil S, Trippler M, Jiang M, et al. 2010. The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. Gut 59:1111-19
128. Kim MJ, Yoo JY. 2010. Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J. Immunol. 185:4311-18
129. Yuan W, Krug RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20:362-71
130. Chang YG, Yan XZ, Xie YY, Gao XC, Song AX, et al. 2008. Different roles for two ubiquitin-like domains of ISG15 in protein modification. J. Biol. Chem. 283:13370-77
131. Sridharan H, Zhao C, Krug RM. 2010. Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins. J. Biol. Chem. 285:7852-56
132. Versteeg GA, Hale BG, Van Boheemen S, WolffT, Lenschow DJ, Garcia-Sastre A. 2010. Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. J. Virol. 84:5423-30
133. Guerra S, Caceres A, Knobeloch KP, Horak I, EstebanM. 2008. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog. 4:e1000096
134. Frias-Staheli N, Giannakopoulos NV, Kikkert M, Taylor SL, Bridgen A, et al. 2007. Ovarian tumor domain-containing viral proteases evade ubiquitin-and ISG15-dependent innate immune responses. Cell Host Microbe 2:404-16
135. Clementz MA, Chen Z, Banach BS, Wang Y, Sun L, et al. 2010. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J. Virol. 84:4619-29
136. LindnerHA, Lytvyn V, Qi H, Lachance P, Ziomek E, Menard R. 2007. Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease. Arch. Biochem. Biophys. 466:8-14
137. Karpe YA, Lole KS. 2011. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease. J. Gen. Virol. 92:2088-92
138. Akutsu M, Ye Y, Virdee S, Chin JW, Komander D. 2011. Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc. Natl. Acad. Sci. USA 108:2228-33
139. James TW, Frias-Staheli N, Bacik JP, Levingston Macleod JM, Khajehpour M, et al. 2011. Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domaincontaining protease. Proc. Natl. Acad. Sci. USA 108:2222-27
140. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. USA 102:10200-5
141. Jeon YJ, Choi JS, Lee JY, Yu KR, Kim SM, et al. 2009. ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway. EMBO Rep. 10:374-80
142. Shi HX, Yang K, Liu X, Liu XY, Wei B, et al. 2010. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol. Cell. Biol. 30:2424-36
143. Zhao C, Hsiang TY, Kuo RL, Krug RM. 2010. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc. Natl. Acad. Sci. USA 107:2253-58
144. Tang Y, Zhong G, Zhu L, Liu X, Shan Y, et al. 2010. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J. Immunol. 184:5777-90
145. Malakhova OA, Zhang DE. 2008. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J. Biol. Chem. 283:8783-87
146. Okumura A, Pitha PM, Harty RN. 2008. ISG15 inhibits Ebola VP40 VLP budding in an L-domaindependent manner by blocking Nedd4 ligase activity. Proc. Natl. Acad. Sci. USA 105:3974-79
147. Okumura A, Lu G, Pitha-Rowe I, Pitha PM. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. USA 103:1440-45
148. Kuang Z, Seo EJ, Leis J. 2011. Mechanism of inhibition of retrovirus release from cells by interferoninduced gene ISG15. J. Virol. 85:7153-61
149. Takeuchi T, Yokosawa H. 2005. ISG15 modification of Ubc13 suppresses its ubiquitin-conjugating activity. Biochem. Biophys. Res. Commun. 336:9-13
150. Zou W, Papov V, Malakhova O, Kim KI, Dao C, et al. 2005. ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. Biochem. Biophys. Res. Commun. 336:61-68
151. Desai SD, Haas AL, Wood LM, Tsai YC, Pestka S, et al. 2006. Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway. Cancer Res. 66:921-28
152. Zhang D, Zhang DE. 2011. Interferon-stimulated gene 15 and the protein ISGylation system. J. Interferon Cytokine Res. 31:119-30
153. Durfee LA, LyonN, Seo K, Huibregtse JM. 2010. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol. Cell 38:722-32
154. D'Cunha J, Ramanujam S, Wagner RJ, Witt PL, Knight E Jr, Borden EC. 1996. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J. Immunol. 157:4100-8
155. Recht M, Borden EC, Knight E Jr. 1991. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J. Immunol. 147:2617-23
156. Padovan E, Terracciano L, Certa U, Jacobs B, Reschner A, et al. 2002. Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells. Cancer Res. 62:3453-58
157. Owhashi M, Taoka Y, Ishii K, Nakazawa S, Uemura H, Kambara H. 2003. Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor. Biochem. Biophys. Res. Commun. 309:533-39
158. Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, et al. 2011. ISG15 is critical in the control of chikungunya virus infection independent of UbE1L-mediated conjugation. PLoS Pathog. 7:e1002322
159. Malakhova OA, KimKI, Luo JK, ZouW, KumarKG, et al. 2006. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25:2358-67
160. Malakhova OA, Yan M, Malakhov MP, Yuan Y, Ritchie KJ, et al. 2003. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev. 17:455-60
161. Ritchie KJ, Malakhov MP, Hetherington CJ, Zhou L, Little MT, et al. 2002. Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev. 16:2207-12
162. Knobeloch KP, UtermohlenO, Kisser A, Prinz M, Horak I. 2005. Reexamination of the role of ubiquitinlike modifier ISG15 in the phenotype of UBP43-deficient mice. Mol. Cell. Biol. 25:11030-34
163. Kim JH, Luo JK, Zhang DE. 2008. The level of hepatitis B virus replication is not affected by protein ISG15modification but is reduced by inhibition of UBP43 (USP18) expression. J. Immunol. 181:6467-72
164. PelzerC, Groettrup M. 2010. FAT10: activated by UBA6 and functioning in protein degradation. Subcell. Biochem. 54:238-46
165. Aichem A, Pelzer C, Lukasiak S, Kalveram B, Sheppard PW, et al. 2010. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis. Nat. Commun. 1:13
166. Chiu YH, Sun Q, Chen ZJ. 2007. E1-L2 activates both ubiquitin and FAT10. Mol. Cell 27:1014-23
167. Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G. 2005. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol. Cell. Biol. 25:3483-91
168. Schmidtke G, Kalveram B, Groettrup M. 2009. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L. FEBS Lett. 583:591-94
169. Schmidtke G, Kalveram B, Weber E, Bochtler P, Lukasiak S, et al. 2006. The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10. J. Biol. Chem. 281:20045-54
170. Buchsbaum S, Bercovich B, Ciechanover A. 2011. FAT10 is a proteasomal degradation signal which is itself regulated by ubiquitination. Mol. Biol. Cell 23:225-32
171. Gong P, Canaan A, Wang B, Leventhal J, Snyder A, et al. 2010. The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J. Am. Soc. Nephrol. 21:316-26
172. Li T, Santockyte R, Yu S, Shen RF, Tekle E, et al. 2011. FAT10 modifies p53 and upregulates its transcriptional activity. Arch. Biochem. Biophys. 509:164-69
173. Ebstein F, Lange N, Urban S, Seifert U, Kruger E, Kloetzel PM. 2009. Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitin-proteasome system. Int. J. Biochem. Cell Biol. 41:1205-15
174. Canaan A, Yu X, Booth CJ, Lian J, Lazar I, et al. 2006. FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol. Cell. Biol. 26:5180-89
175. Snyder A, Alsauskas Z, Gong P, Rosenstiel PE, Klotman ME, et al. 2009. FAT10: a novel mediator of Vpr-induced apoptosis in human immunodeficiency virus-associated nephropathy. J. Virol. 83:11983-88
176. Jeram SM, Srikumar T, Pedrioli PG, Raught B. 2009. Using mass spectrometry to identify ubiquitin and ubiquitin-like protein conjugation sites. Proteomics 9:922-34
177. Nakamura M, Shimosaki S. 2009. The ubiquitin-like protein monoclonal nonspecific suppressor factor beta conjugates to endophilin II and regulates phagocytosis. FEBS J. 276:6355-63
178. NakamuraM, Yamaguchi S. 2006. The ubiquitin-like protein MNSFbeta regulatesERK-MAPKcascade. J. Biol. Chem. 281:16861-69
179. Kondoh T, Nakamura M, Nabika T, Yoshimura Y, Tanigawa Y. 1999. Ubiquitin-like polypeptide inhibits the proliferative response of T cells in vivo. Immunobiology 200:140-49
180. Komatsu M, Chiba T, Tatsumi K, Iemura S, Tanida I, et al. 2004. A novel protein-conjugating system for Ufm1, a ubiquitin-fold modifier. EMBO J. 23:1977-86
181. Tatsumi K, Sou YS, Tada N, Nakamura E, Iemura S, et al. 2010. A novel type of E3 ligase for the Ufm1 conjugation system. J. Biol. Chem. 285:5417-27
182. Levine B, MizushimaN, VirginHW. 2011. Autophagy in immunity and inflammation. Nature 469:323-35
183. Geng J, Klionsky DJ. 2008. The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. "Protein modifications: beyond the usual suspects" review series. EMBO Rep. 9:859-64
184. Fujita N, Itoh T, Omori H, Fukuda M, Noda T, Yoshimori T. 2008. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol. Biol. Cell 19:2092-100
185. Hanada T, Noda NN, Satomi Y, Ichimura Y, Fujioka Y, et al. 2007. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J. Biol. Chem. 282:37298-302
186. Radoshevich L, Murrow L, Chen N, Fernandez E, Roy S, et al. 2010. ATG12 conjugation to ATG3 regulates mitochondrial homeostasis and cell death. Cell 142:590-600
187. Taherbhoy AM, Tait SW, Kaiser SE, Williams AH, Deng A, et al. 2011. Atg8 transfer from Atg7 to Atg3: a distinctive E1-E2 architecture and mechanism in the autophagy pathway. Mol. Cell 44:451-61
188. Noda NN, Satoo K, Fujioka Y, Kumeta H, Ogura K, et al. 2011. Structural basis of Atg8 activation by a homodimeric E1, Atg7. Mol. Cell 44:462-75
189. Hong SB, Kim BW, Lee KE, Kim SW, Jeon H, et al. 2011. Insights into noncanonical E1 enzyme activation from the structure of autophagic E1 Atg7 with Atg8. Nat. Struct. Mol. Biol. 18:1323-30
190. Nakatogawa H, Ichimura Y, Ohsumi Y. 2007. Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion. Cell 130:165-78
191. Xie Z, Nair U, Klionsky DJ. 2008. Atg8 controls phagophore expansion during autophagosome formation. Mol. Biol. Cell 19:3290-98
192. Nair U, Jotwani A, Geng J, Gammoh N, Richerson D, et al. 2011. SNARE proteins are required for macroautophagy. Cell 146:290-302
193. Moreau K, RavikumarB, RennaM, Puri C, RubinszteinDC. 2011. Autophagosome precursor maturation requires homotypic fusion. Cell 146:303-17
194. Behrends C, Sowa ME, Gygi SP, Harper JW. 2010. Network organization of the human autophagy system. Nature 466:68-76
195. Chakrama FZ, Seguin-Py S, Le Grand JN, Fraichard A, Delage-Mourroux R, et al. 2010. GABARAPL1 (GEC1) associates with autophagic vesicles. Autophagy 6:495-505
196. Weidberg H, Shvets E, Shpilka T, Shimron F, Shinder V, Elazar Z. 2010. LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J. 29:1792-802
197. Weidberg H, Shpilka T, Shvets E, Abada A, Shimron F, Elazar Z. 2011. LC3 and GATE-16 N termini mediate membrane fusion processes required for autophagosome biogenesis. Dev. Cell 20:444-54
198. Coyle JE, Qamar S, Rajashankar KR, Nikolov DB. 2002. Structure of GABARAP in two conformations: implications for GABA(A) receptor localization and tubulin binding. Neuron 33:63-74
199. Ichimura Y, Imamura Y, Emoto K, Umeda M, Noda T, Ohsumi Y. 2004. In vivo and in vitro reconstitution of Atg8 conjugation essential for autophagy. J. Biol. Chem. 279:40584-92
200. Itoh T, Kanno E, Uemura T, Waguri S, Fukuda M. 2011. OATL1, a novel autophagosome-resident Rab33B-GAP, regulates autophagosomal maturation. J. Cell Biol. 192:839-53
201. Kirkin V, McEwan DG, Novak I, Dikic I. 2009. A role for ubiquitin in selective autophagy. Mol. Cell 34:259-69
202. Kirkin V, Lamark T, Sou YS, Bjorkoy G, Nunn JL, et al. 2009. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol. Cell 33:505-16
203. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, et al. 2007. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131:1149-63
204. Novak I, Kirkin V, McEwan DG, Zhang J, Wild P, et al. 2010. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep. 11:45-51
205. Youle RJ, Narendra DP. 2011. Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 12:9-14
206. Thurston TL, Ryzhakov G, Bloor S, von Muhlinen N, Randow F. 2009. The TBK1 adaptor and autophagy receptorNDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat. Immunol. 10:1215-21
207. Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, et al. 2011. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333:228-33
208. Zheng YT, Shahnazari S, Brech A, Lamark T, Johansen T, Brumell JH. 2009. The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway. J. Immunol. 183:5909-16
209. Ponpuak M, Davis AS, Roberts EA, Delgado MA, Dinkins C, et al. 2010. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 32:329-41
210. Noda NN, Kumeta H, Nakatogawa H, Satoo K, Adachi W, et al. 2008. Structural basis of target recognition by Atg8/LC3 during selective autophagy. Genes Cells 13:1211-18
211. Noda NN, Ohsumi Y, Inagaki F. 2010. Atg8-family interacting motif crucial for selective autophagy. FEBS Lett. 584:1379-85
212. Shvets E, Abada A, Weidberg H, Elazar Z. 2011. Dissecting the involvement of LC3B and GATE-16 in p62 recruitment into autophagosomes. Autophagy 7:683-88
213. Ichimura Y, Kumanomidou T, Sou YS, Mizushima T, Ezaki J, et al. 2008. Structural basis for sorting mechanism of p62 in selective autophagy. J. Biol. Chem. 283:22847-57
214. Rozenknop A, Rogov VV, RogovaNY, Lohr F, Guntert P, et al. 2011. Characterization of the interaction of GABARAPL-1 with the LIR motif of NBR1. J. Mol. Biol. 410:477-87
215. Hemelaar J, Lelyveld VS, Kessler BM, Ploegh HL. 2003. A single protease, Apg4B, is specific for the autophagy-related ubiquitin-like proteins GATE-16, MAP1-LC3, GABARAP, and Apg8L. J. Biol.Chem. 278:51841-50
216. Cabrera S, MarinoG, Fernandez AF, Lopez-Otin C. 2010. Autophagy, proteases and the sense of balance. Autophagy 6:961-63
217. Betin VM, Lane JD. 2009. Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis. J. Cell Sci. 122:2554-66
218. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z. 2007. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26:1749-60
219. Nair U, Cao Y, Xie Z, Klionsky DJ. 2010. Roles of the lipid-binding motifs of Atg18 and Atg21 in the cytoplasm to vacuole targeting pathway and autophagy. J. Biol. Chem. 285:11476-88
220. Burroughs AM, Iyer LM, Aravind L. 2011. Functional diversification of the RING finger and other binuclear treble clef domains in prokaryotes and the early evolution of the ubiquitin system. Mol. Biosyst. 7:2261-77
221. Iyer LM, BurroughsAM, AravindL. 2006. The prokaryotic antecedents of the ubiquitin-signaling system and the early evolution of ubiquitin-like beta-grasp domains. Genome Biol. 7:R60
222. Rudolph MJ, Wuebbens MM, Rajagopalan KV, Schindelin H. 2001. Crystal structure of molybdopterin synthase and its evolutionary relationship to ubiquitin activation. Nat. Struct. Biol. 8:42-46
223. Wang C, Xi J, Begley TP, Nicholson LK. 2001. Solution structure of ThiS and implications for the evolutionary roots of ubiquitin. Nat. Struct. Biol. 8:47-51
224. Burroughs AM, Iyer LM, Aravind L. 2009. Natural history of the E1-like superfamily: implication for adenylation, sulfur transfer, and ubiquitin conjugation. Proteins 75:895-910
225. Lake MW, Wuebbens MM, Rajagopalan KV, Schindelin H. 2001. Mechanism of ubiquitin activation revealed by the structure of a bacterial MoeB-MoaD complex. Nature 414:325-29
226. Xi J, Ge Y, Kinsland C, McLafferty FW, Begley TP. 2001. Biosynthesis of the thiazole moiety of thiamin in Escherichia coli: identification of an acyldisulfide-linked protein-protein conjugate that is functionally analogous to the ubiquitin/E1 complex. Proc. Natl. Acad. Sci. USA 98:8513-18
227. Furukawa K, Mizushima N, Noda T, Ohsumi Y. 2000. A protein conjugation system in yeast with homology to biosynthetic enzyme reaction of prokaryotes. J. Biol. Chem. 275:7462-65
228. Xu J, Zhang J, Wang L, Zhou J, Huang H, et al. 2006. Solution structure of Urm1 and its implications for the origin of protein modifiers. Proc. Natl. Acad. Sci. USA 103:11625-30
229. Singh S, Tonelli M, Tyler RC, Bahrami A, Lee MS, Markley JL. 2005. Three-dimensional structure of the AAH26994.1 protein from Mus musculus, a putative eukaryotic Urm1. Protein Sci. 14:2095-102
230. Leidel S, Pedrioli PG, Bucher T, Brost R, Costanzo M, et al. 2009. Ubiquitin-related modifier Urm1 acts as a sulphur carrier in thiolation of eukaryotic transfer RNA. Nature 458:228-32
231. Noma A, Sakaguchi Y, Suzuki T. 2009. Mechanistic characterization of the sulfur-relay system for eukaryotic 2-thiouridine biogenesis at tRNA wobble positions. Nucleic Acids Res. 37:1335-52
232. Schlieker CD, Van der Veen AG, Damon JR, Spooner E, Ploegh HL. 2008. A functional proteomics approach links the ubiquitin-related modifier Urm1 to a tRNA modification pathway. Proc. Natl. Acad. Sci. USA 105:18255-60
233. Schmitz J, Chowdhury MM, Hanzelmann P, Nimtz M, Lee EY, et al. 2008. The sulfurtransferase activity of Uba4 presents a link between ubiquitin-like protein conjugation and activation of sulfur carrier proteins. Biochemistry 47:6479-89
234. Marelja Z, Stocklein W, Nimtz M, Leimkuhler S. 2008. A novel role for human Nfs1 in the cytoplasm: Nfs1 acts as a sulfur donor forMOCS3, a protein involved in molybdenum cofactor biosynthesis. J. Biol. Chem. 283:25178-85
235. Matthies A, Rajagopalan KV, Mendel RR, Leimkuhler S. 2004. Evidence for the physiological role of a rhodanese-like protein for the biosynthesis of the molybdenum cofactor in humans. Proc. Natl. Acad. Sci. USA 101:5946-51
236. Yu J, Zhou CZ. 2008. Crystal structure of the dimeric Urm1 from the yeast Saccharomyces cerevisiae. Proteins 71:1050-55
237. Nakai Y, Nakai M, Hayashi H. 2008. Thio-modification of yeast cytosolic tRNA requires a ubiquitinrelated system that resembles bacterial sulfur transfer systems. J. Biol. Chem. 283:27469-76
238. Agris PF. 2008. Bringing order to translation: the contributions of transfer RNA anticodon-domain modifications. EMBO Rep. 9:629-35
239. Nakai Y, Umeda N, Suzuki T, Nakai M, Hayashi H, et al. 2004. Yeast Nfs1p is involved in thiomodification of both mitochondrial and cytoplasmic tRNAs. J. Biol. Chem. 279:12363-68
240. Bjork GR, Huang B, Persson OP, Bystrom AS. 2007. A conserved modified wobble nucleoside (mcm5s2U) in lysyl-tRNA is required for viability in yeast. RNA 13:1245-55
241. DewezM, Bauer F, Dieu M, Raes M, Vandenhaute J, Hermand D. 2008. The conserved wobble uridine tRNA thiolase Ctu1-Ctu2 is required tomaintain genome integrity. Proc. Natl. Acad. Sci. USA 105:5459-64
242. Huang B, Lu J, Bystrom AS. 2008. A genome-wide screen identifies genes required for formation of the wobble nucleoside 5-methoxycarbonylmethyl-2- thiouridine in Saccharomyces cerevisiae. RNA 14:2183-94
243. Chen C, Tuck S, Bystrom AS. 2009. Defects in tRNA modification associated with neurological and developmental dysfunctions in Caenorhabditis elegans elongator mutants. PLoS Genet. 5:e1000561
244. Goehring AS, Rivers DM, Sprague GF Jr. 2003. Attachment of the ubiquitin-related protein Urm1p to the antioxidant protein Ahp1p. Eukaryot. Cell 2:930-36
245. Goehring AS, Rivers DM, Sprague GF Jr. 2003. Urmylation: a ubiquitin-like pathway that functions during invasive growth and budding in yeast. Mol. Biol. Cell 14:4329-41
246. Huang B, JohanssonMJ, Bystrom AS. 2005. An early step in wobble uridine tRNA modification requires the Elongator complex. RNA 11:424-36
247. Frohloff F, Fichtner L, JablonowskiD, BreunigKD, SchaffrathR. 2001. Saccharomyces cerevisiae Elongator mutations confer resistance to the Kluyveromyces lactis zymocin. EMBO J. 20:1993-2003
248. Van der Veen AG, Schorpp K, Schlieker C, Buti L, Damon JR, et al. 2011. Role of the ubiquitin-like proteinUrm1 as a noncanonical lysine-directed protein modifier. Proc. Natl. Acad. Sci. USA 108:1763-70
249. Burns KE, Darwin KH. 2010. Pupylation versus ubiquitylation: tagging for proteasome-dependent degradation. Cell Microbiol. 12:424-31
250. Humbard MA, Miranda HV, Lim JM, Krause DJ, Pritz JR, et al. 2010. Ubiquitin-like small archaeal modifier proteins (SAMPs) in Haloferax volcanii. Nature 463:54-60
251. Ranjan N, Damberger FF, Sutter M, Allain FH, Weber-Ban E. 2010. Solution structure and activation mechanism of ubiquitin-like small archaeal modifier proteins. J. Mol. Biol. 405:1040-55
252. Miranda HV, Nembhard N, Su D, Hepowit N, Krause DJ, et al. 2011. E1-and ubiquitin-like proteins provide a direct link between protein conjugation and sulfur transfer in archaea. Proc. Natl. Acad. Sci. USA 108:4417-22
253. Nunoura T, Takaki Y, Kakuta J, Nishi S, Sugahara J, et al. 2010. Insights into the evolution of Archaea and eukaryotic protein modifier systems revealed by the genome of a novel archaeal group. Nucleic Acids Res. 39:3204-23
254. Dittmar GA, Wilkinson CR, Jedrzejewski PT, Finley D. 2002. Role of a ubiquitin-like modification in polarized morphogenesis. Science 295:2442-46
255. Yashiroda H, Tanaka K. 2004. Hub1 is an essential ubiquitin-like protein without functioning as a typical modifier in fission yeast. Genes Cells 9:1189-97
256. Luders J, Pyrowolakis G, Jentsch S. 2003. The ubiquitin-like protein HUB1 forms SDS-resistant complexes with cellular proteins in the absence of ATP. EMBO Rep. 4:1169-74
257. Wilkinson CR, Dittmar GA, Ohi MD, Uetz P, Jones N, Finley D. 2004. Ubiquitin-like protein Hub1 is required for pre-mRNA splicing and localization of an essential splicing factor in fission yeast. Curr. Biol. CB 14:2283-88
258. Pankiv S, Alemu EA, Brech A, Bruun JA, Lamark T, et al. 2010. FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end-directed vesicle transport. J. Cell Biol. 188:253-69